CDKN2A and cancer: However, only CDKN2A status remained significant (HR: 1.72, 95% CI: 1.34–2.21, p < 0.001, Supplemental Figure S2) after adjusting for age at metastatic diagnosis, gender, and cancer type in the multivariate Cox regression models.